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Introduction: The genesis of atrial fibrillation (AF) and success of AF ablation
therapy have been strongly linked with atrial fibrosis. Increasing evidence suggests that
patient-specific distributions of fibrosis may determine the locations of electrical drivers
(rotors) sustaining AF, but the underlying mechanisms are incompletely understood.
This study aims to elucidate a missing mechanistic link between patient-specific fibrosis
distributions and AF drivers.
Methods: 3D atrial models integrated human atrial geometry, rule-based fiber
orientation, region-specific electrophysiology, and AF-induced ionic remodeling. A novel
detailed model for an atrial fibroblast was developed, and effects of myocyte-fibroblast
(M-F) coupling were explored at single-cell, 1D tissue and 3D atria levels. Left atrial LGE
MRI datasets from 3 chronic AF patients were segmented to provide the patient-specific
distributions of fibrosis. The data was non-linearly registered and mapped to the 3D atria
model. Six distinctive fibrosis levels (0–healthy tissue, 5–dense fibrosis) were identified
based on LGE MRI intensity and modeled as progressively increasing M-F coupling and
decreasing atrial tissue coupling. Uniform 3D atrial model with diffuse (level 2) fibrosis
was considered for comparison.
Results: In single cells and tissue, the largest effect of atrial M-F coupling was
on the myocyte resting membrane potential, leading to partial inactivation of sodium
current and reduction of conduction velocity (CV). In the 3D atria, further to the M-F
coupling, effects of fibrosis on tissue coupling greatly reduce atrial CV. AF was initiated
by fast pacing in each 3D model with either uniform or patient-specific fibrosis. High
variation in fibrosis distributions between the models resulted in varying complexity
of AF, with several drivers emerging. In the diffuse fibrosis models, waves randomly
meandered through the atria, whereas in each the patient-specific models, rotors
stabilized in fibrotic regions. The rotors propagated slowly around the border zones
of patchy fibrosis (levels 3–4), failing to spread into inner areas of dense fibrosis.
Morgan et al. Fibrosis and Stability of Drivers for Atrial Fibrillation
Conclusion: Rotors stabilize in the border zones of patchy fibrosis in 3D atria, where
slow conduction enable the development of circuits within relatively small regions. Our
results can provide a mechanistic explanation for the clinical efficacy of ablation around
fibrotic regions.
Keywords: atrial fibrillation, fibrosis, modeling and simulation, arrhythmia mechanisms, MR imaging
INTRODUCTION
Atrial fibrillation (AF) is the most common sustained cardiac
arrhythmia, affecting 6 million people in Europe alone and
imposing a huge healthcare burden on the society. Despite
well-developed clinical guidelines for the management of AF,
anti-arrhythmic therapy success rates remain suboptimal due
to complexity of the disease and lack of knowledge of its
mechanisms (Calkins et al., 2012). Catheter ablation is a standard
clinical treatment aimed at eliminating the arrhythmogenic
electrical drivers in the atria by destroying the underlying tissue
substrate with a localized energy delivery. However, precise driver
locations in a patient are generally unknown, and the long-
term success rates of empirical ablation procedures (such as the
pulmonary vein isolation) are low, with the disease recurring
in 30–50% of patients (Schotten et al., 2011; Calkins et al.,
2012).
Both the genesis of AF and success of ablation therapy have
been strongly linked with atrial fibrosis (Marrouche et al., 2014;
Gal and Marrouche, 2015; Kottkamp et al., 2015). Fibrosis levels
are higher in AF patients compared to healthy subjects and
correlate positively with AF recurrence (Marrouche et al., 2014)
after ablation. Moreover, ablation around fibrotic areas identified
from late-gadolinium enhanced (LGE)MRI (Gal andMarrouche,
2015) or electro-anatomical mapping (Kottkamp et al., 2015) has
been shown to improve therapy success rates. Mechanistically,
structural and functional tissue heterogeneities associated with
fibrosis have generally been linked to arrhythmogenesis, for
example in ventricular infarction border zones (BZ) (Rutherford
et al., 2012). Such border heterogeneities can be presented as
large collagen deposits within the functional myocardium, which
can slow down or block the propagation of electrical excitation
waves, creating conditions for the generation and sustenance of
re-entrant drivers (rotors).
Recent studies (Jadidi et al., 2013; Haissaguerre et al., 2016)
have demonstrated that areas adjacent to dense fibrosis in the
atria have also shown high levels of arrhythmogenic activity.
These myocardial areas, whilst still fibrotic, are not damaged
sufficiently to fully inhibit wave propagation and have a high
correlation to complex high-frequency electrical activity (Jadidi
et al., 2013). Structurally and functionally these regions are
reminiscent of ventricular infarction BZs, which commonly
surround dense fibrotic areas (such as scar) and have also
been shown to exhibit low levels of electrical activity. This
similarity suggests that patient-specific distributions of atrial
fibrosis can also determine the dynamics of electrical drivers
sustaining AF. A recent computational study has shown that
AF can be perpetuated by rotors persisting in fibrotic BZs with
specific statistical characteristics (Zahid et al., 2016). However,
mechanistic links between atrial fibrosis and the genesis of AF
drivers are unclear.
Computational modeling provides a powerful tool for
integrating multi-scale atrial data and dissecting the mechanisms
of arrhythmia and anti-arrhythmic treatments in-silico, (Colman
et al., 2013; McDowell et al., 2015; Zahid et al., 2016) which is
extremely challenging in a purely experimental or clinical setting.
Recent computational studies have shown the importance of
heterogeneities associated with fibrosis, (McDowell et al., 2015;
Zahid et al., 2016) as well as other factors, (Aslanidi et al., 2011;
Colman et al., 2013) in the generation and sustenance of AF.
However, even the most advanced models have only considered
step-wise heterogeneities, such as discontinuous transitions from
healthy or fibrotic tissue with no genuine transitional zone (Zahid
et al., 2016)—and hence, have not explored the mechanistic
effects of patchy fibrotic BZs. Besides, electrophysiological
models developed for ventricular (rather than atrial) fibroblasts
have commonly been utilized (McDowell et al., 2015).
The current study aims to develop both a novel model for
atrial fibroblast, and a novel image-based approach to modeling
gradual transitions in properties between healthy and fibrotic
atrial tissue. These novel electrophysiological and structural
data will be integrated into multi-scale biophysical models
of the 3D human atria. The detailed models will then be
applied to substantiate mechanistic links between patient-specific
distributions of fibrosis and location of drivers sustaining AF.
Specifically, we will explore a hypothesis that rotors preferentially
propagate around the slow conducting BZs of patchy fibrosis,
which can provide a mechanistic explanation for the improved
outcomes of ablation around fibrotic areas.
METHODS
Several authors of this study have recently contributed to the
creation of an integrative biophysical model for the entire 3D
human atria (Aslanidi et al., 2011; Colman et al., 2013). The
model included: (i) detailed atrial electrophysiology based on
the Courtemanche-Ramirez-Nattel (Courtemanche et al., 1998)
(CRN) atrial myocyte model; (ii) regional heterogeneity in the
ionic channel and action potential (AP) properties, and their
changes due to AF-induced ionic remodeling, reflected in the
respective variations of the CRN model parameters; (iii) atrial
geometry provided by the Visible Female anatomical dataset,
with the 3D atria segmented into major anatomical regions
(Colman et al., 2013). In the current study, the model was
further developed to include: (iv) rule-based fiber orientation
throughout the entire 3D atria (see in the Supplementary
Figure 1; Krueger et al., 2011); (v) a novel model for atrial
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fibroblast electrophysiology and electrotonic myocyte-fibroblast
(M-F) coupling; (vi) patient-specific distributions of fibrosis
reconstructed from LGE MRI data and mapped onto the 3D
atria model, which accounted for gradual changes of the tissue
properties between healthy and fibrotic atrial regions. Detailed
description of the existing model components (i–iii), as well
as (iv), can be found in previous publications (Aslanidi et al.,
2011; Krueger et al., 2011; Colman et al., 2013), and the novel
components (v,vi) are described in detail below.
Atrial Fibroblast Electrophysiology
Unlike myocytes, fibroblasts are not electrically excitable,
however they can maintain a resting membrane potential (RMP),
and hence affect and be affected by the tissue electrophysiology.
The electrophysiological function of fibroblasts is determined by
the presence of a range of ionic channel currents in their cell
membrane. It is known that both cultured and freshly isolated
fibroblasts express voltage dependant potassium channels (IKv)
(Chilton et al., 2005). A wide variety of currents have now been
discovered in the cardiac fibroblast, predominantly potassium
(IKur , IKir , Ito), but also non-specific ionic currents (Ins) which
can be mechanically and non-mechanically activated chlorine
currents (ICl). The sources of data for these various currents are
diverse, and are summarized in Table 1.
The general approach to modeling atrial fibroblast
electrophysiology was based on a well-established ventricular
fibroblast model by MacCannell et al. (2007). However, a
set of ionic channel currents specific to atrial fibroblasts was
considered, based on the CRN formulation of the currents
for human atrial myocytes and experimental data from atrial
fibroblasts. Data for the atrial fibroblast model was obtained
from a study (Wu et al., 2014) on ionic currents in freshly
isolated canine atrial fibroblasts. An optimal fit between the
modeled ionic currents and experimental data was achieved by
varying the current conductances (see Results below). Note that
the dog has been widely used as an experimental model for AF
(Schotten et al., 2011), and in the absence of ionic current data
from human fibroblasts it is sensible to propose that the canine
data provides the closest match.
The 4-aminopyridine (4-AP) sensitive current was modeled as
Ito, f , which is selectively blocked by 4-AP. Fitting the current-
voltage (I–V) relationship for this current to experimental
data by Wu et al. (2014) involved a 90% reduction in the
current conductance compared to its original formulation in the
CRN model, but no changes to the CRN current kinetics was
introduced.
The S9941 sensitive current was modeled as IKur, f , as S9941
is a blocker of ionic channels containing the subunit Kv1.5,
which forms the channel conducting this current. Fitting the I-
V relationship for this current to experimental data by Wu et al.
(2014) involved a 40% reduction in the current conductance
compared to its original formulation in the CRN model.
The end pulse current was measured by Wu et al. (2014) as
the total voltage sensitive current. We considered the remainder
of this current after subtracting both Ito, f and IKur, f as a sum of a
further two currents: a linear non-specific ionic channel current,
Ins, f , and the inward-rectifier potassium channel current, IK1, f
(see Results below). Both IKur, f and Ins, f are major contributors
to the fibroblast RMP. The separation of these two currents
ensured that IK1, f reversed at the equilibrium Nernst potential
for potassium ions, EK , as is observed in electrophysiological
recordings of this current in multiple cell types. The voltage
and time dependences for these currents are based on the CRN
formulation (index f denotes their relevance to fibroblasts):
IK1, f =
0.03
(
Vf + 86.75
)
(1+ exp (0.05 (Vf + 20)))
(1)
Ins, f = 0.018 Vf (2)
Ito, f = gto, f ∗ oa, f
3
∗ oi, f ∗
(
Vf − EK
)
; (3)
IKur, f = gKur, f ∗ ua, f
3
∗ ui, f ∗
(
Vf − EK
)
; (4)
Here, Vf is the membrane voltage of fibroblasts, where oa, f , ua, f
and oi, f , ui, f are activation and inactivation gates, respectively,
and gKur and gto are conductances of the respective channels.
The other two currents in the developed atrial fibroblast
model are based on the MacCannell et al. (2007) formulation.
Specifically, there are currents not measured by Wu et al. (2014)
but assumed present in the atrial fibroblast based on experimental
studies with other cardiac cells. These are the sodium-potassium
exchange current (INaK) and the background sodium current
(IbNa).
Note that in the MacCannell et al. (2007) model and its
derivatives, only IK1 and the time and voltage dependant
potassium current IKv are included. The latter current was shown
to be sensitive to 4-AP and S9941 in their experimental work,
(Shibukawa et al., 2005) and hence is likely to present a sum of
Ito, f and IKur, f . However, unlike our novel model, MacCannell
et al. (2007) modeled it as a single current.
M-F electrotonic coupling mechanism is based on the
presence ofM-F gap junctions (Rook et al., 1992; Gaudesius et al.,
2003; Camelliti et al., 2004), in the samemanner as inter-myocyte
coupling. In order to simulate the M-F coupling, we used a
similar formalism to that developed by MacCannell et al. (2007).
Specifically, the CRN atrial myocyte (with the total membrane
ionic current Itot) was coupled with the novel atrial fibroblast
(with a total membrane ionic current Itot, f ) via a linear M-F gap
junctional conductance (Ggap):
Itot, f =
∑
Iion, f = Ito, f + IK1, f + IKur, f + Ins, f
+ IbNa, f + INaK, f (5)
dVf
dt
= −
1
Cmf
[
Itot, f (Vf , t)+ Ggap (Vf − Vm)
]
(6)
dVm
dt
= −
1
Cm
[
Itot (Vm, t)+
n∑
i= 1
Ggap (Vm − Vf )
]
(7)
Here Cm is the membrane capacitance, subscripts m and f relate
to a myocyte and fibroblast, and n to the number of fibroblasts
coupled to one myocyte. Ggap was set as 0.5 nS (Jacquemet and
Henriquez, 2008) and n was varied between 0 and 6. Unless
specified otherwise, a myocyte was coupled to 2 fibroblasts.
Patient-Specific Fibrosis Imaging
The images with distributions of atrial fibrosis used in this
study were obtained from 3 patients suffering persistent AF
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TABLE 1 | Electrophysiological properties of cardiac fibroblasts.
Study Fibroblast RMP Currents Cell type Cell source
Shibukawa et al., 2005 −58 ± 3.9 mV Ins, IKv Adult rat ventricle
Chilton et al., 2005 - IK1, IKv Rat ventricle Isolated
Kiseleva et al., 1998 −22 mV - Rat atria Isolated
Rook et al., 1992 −20 ÷ −30 mV - Neonatal rat Cultured
Kamkin et al., 2003 −37 ± 3 mV Ins* Rat atria
Wu et al., 2014 −42.8 mV IKur Canine atria Freshly
Ito Isolated
Wang et al., 2003 - Ins
†, IBKCa
‡ Rat ventricle Cultured
Miragoli et al., 2006 −14 ÷ −25 mV IK1 Neonatal rat ventricle Cultured
Kohl et al., 2005 - ICl, IKv, IK1, INa Frog SAN
Kohl et al., 2005 −15 mV - Rat atria and SAN Isolated and Cultured
Li et al., 2009 - IBKCa, Ito, IK1, ICl** Human ventricle Cultured
The table identifies ionic channel currents and RMP of fibroblasts as reported in literature. *(gadolinium sensitive),
†
(mechanosensitive),
‡
big conductance Ca2+, **(volume
sensitive)-activated K+ current has been reported in some studies of cultured cells.
and recommended for routine, first time pre-ablation imaging.
These data were randomized to ensure patient privacy. A Philips
1.5T MRI scanner was used, and the images were obtained at
1.4 × 1.4 × 4mm3 resolution and saved in DICOM format.
Two MRI modalities were used: LGE MRI (Figures 1A–C)
and early gadolinium (Gd) angiographic imaging (gated MRA)
(Figure 1D). The angiography images were utilized for an
improved segmentation of LGE MRI data (see details below).
These were taken in the same cardiac phase (atrial diastole) with
respiratory gating.
A novel image processing pipeline was developed to
reconstruct and register the LGE MRI data on the fibrosis
distributions with the 3D atria. The pipeline utilizes fibrosis
segmentation tools developed by the CARMA group at the
University of Utah, such as plugins to 3D SlicerTM. This enables
the reconstruction of gradual fibrosis changes as a function of
image intensity.
The extraction of fibrosis data from MR images requires
thresholding of the intensity of the atrial wall. Obtaining the
atrial wall in MRI data is non-trivial (Varela et al., 2015) and
detailed segmentation can only be performed manually due to
the relatively low resolution and signal to noise ratio (SNR).
This process is extremely time consuming and may provide
discrepancies between segmenters. However, the LGEMR images
are acquired in the same session and at the same cardiac phase as
a gatedMRA acquisition, used as a navigation image for planning
ablation procedures. The gated MRA delineates (Figure 1D)
the blood pool which has a high intensity due to the contrast
agent (Gd) and allows for accurate semi-automatic segmentation
of the endocardial surface. This is achieved using a region
growing algorithm within ITK-Snap, which utilizes seed points
that iteratively dilate. The growth is limited by image intensity
gradients. The segmented endocardial surface then is dilated to
provide an epicardial surface. In some cases it required manual
rectification in highly convoluted areas. The dilation is usually
between 3 and 5mm, which corresponds to the variable atrial
wall thickness (Varela et al., 2015). The endocardial volume is
subtracted from the dilated epicardial volume creating a 3D wall
mask.
Utilising tools developed by the CARMA group and
available as a 3D Slicer plugin (http://capulet.med.utah.edu/
namic/cmrslicer/), provides two different methods for fibrosis
segmentation. The first, named “automatic scar segmentation,”
uses a K-means clustering algorithm. This produces a binary
fibrosis model in the masked region, identifying the densest
fibrosis areas. The secondmethod (“thresholdmodel”) collects the
MR intensity data from the masked image applying no threshold
or segmentation. Both methods project the data onto a surface
mesh of the endocardium. This 3D image-based atrial mesh
is registered to a respective 3D mesh of the Visible Human
Female atria using the IRTK-toolkit (https://biomedia.doc.ic.ac.
uk/software/irtk/) using a non-linear deformation. The registered
3D mesh is projected onto the Visible Human dataset using a
“nearest neighbor” algorithm. Fibrosis datasets obtained using
the “threshold” tool are segmented by LGE MRI threshold, with
the threshold values defined on the range of the image intensity
in the masked image.
The range by LGE MRI intensity values corresponding to
fibrosis were calculated individually for each patient, due to the
intensity variation between scans, using the maximum intensity
(MI) as the upper limit (Figure 2B). We hypothesized that
the histogram intensity (Figure 2B) was a result of an overlap
between two intensity distributions corresponding to healthy
and fibrotic tissues (McGann et al., 2008). Thus, the right tail
of the histogram was associated with fibrosis, as described in
previous studies (Figure 2A), and the left tail of the histogram
was associated with healthy tissue.
The range of intensity values was divided into 7, with the
lowest 2/7th being allocated to healthy tissue and each fibrosis
level, 1–5 allocated as a following 1/7th of the range (moving
toward higher values). Due to the densest fibrosis (level 5)
covering less tissue than has previously been associated with
fibrotic scars (Karim et al., 2013), the highest 1/7th of the
range was expanded by 20% (moving toward lower values),
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FIGURE 1 | Patient-specific MRI data. (A–C) Coronal LGE MRI slices through the atria (two atria are labelled in white) with areas of high intensity linked to fibrosis
indicated by the black arrows. (D) Gd angiographic MR image with high-intensity blood volume, which is used in the segmentation of the endocardial surface. Images
in panels (C,D) are from the same patient scan in the same coronal slice.
FIGURE 2 | LGE MRI intensity histograms. (A) Comparison between healthy volunteers (black shading) and fibrotic (gray shading) tissue, from Benito et al. (2015).
Note that this includes the blood pool, with the intensity values normalized by the intensity of blood (hence, the peak at 1 corresponds to blood). The histogram clearly
shows a tail of intensities associated with fibrosis. (B) Masked intensity histogram, i.e., only the intensity of the voxels within the masked atrial wall region. Two
Gaussian curves represent approximations of the distributions of healthy (yellow) and fibrotic (light blue) tissue; the histogram peak (gray line) is the superposition
maximum of these two distributions. The red lines show a range for fibrosis level segmentation. (1) is the lower limit of the diffuse fibrosis (levels 1–3) and (2) shows the
lower limit for the dense fibrosis regions (levels 4, 5). The dashed red line (3) shows the lower limit of the densest (level 5) fibrosis region. The red line denoted MI
shows the maximum intensity from which the fibrosis regions were calculated. MIP, maximum intensity projection; IIR, image intensity ratio.
with all other parts of the range evenly reduced. This provided
significant regions of dense fibrosis in agreement with previous
reconstructions. The resultant intensity distribution between
levels was as follows: healthy tissue, 0 to 0.27 MI; level 1, 0.27–0.4
MI; level 2, 0.4–0.55 MI; level 3, 0.55–0.69 MI; level 4, 0.69–0.82
MI; level 5, 0.82–1.0 MI. The segmented fibrosis regions were
considered to be transmurally uniform in the 3D atrial model.
To investigate the role of segmentation variation, we also
created two alternative segmentations for each LGEMRI dataset,
one with a higher and another with a lower threshold. The higher
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threshold case in described above, and the lower threshold case
was created by shifting the threshold of dense fibrosis (dashed
line in Figure 2B) leftward by 10 units of LGE MRI intensity.
3D Atrial Simulations
For the whole atrial simulations, the monodomain equation was
solved on the 3D human atrial geometry with zero-flux boundary
conditions, using the forward Euler method with spatial and
temporal steps of 0.3 mm and 0.005 ms, respectively. The
equation is as follows:
∂Vm
∂t
= ∇ · (D∇Vm)−
Itot
Cm
(8)
Here ∇ is the gradient operator and D is the diffusion coefficient,
which can be a tensor when the tissue is anisotropic. The model
uses the 3D fiber vector array to calculate the diffusion tensor
to each voxel dependant on the orientation of the fiber (Clayton
et al., 2011; Colman et al., 2014). This calculation also requires
the longitudinal and transverse diffusion coefficients,DL andDT ,
where DL was constant at 0.3 mm
2/ms and DT was varied to
change the anisotropy ratio, R= DL /DT , as described below.
The model settings were varied to simulate different
conditions linked to fibrosis and AF. Four types of AF-associated
remodeling were considered: (1) Ionic remodeling (Colman et al.,
2013, 2014), but no structural remodeling (the standard values of
DL = 0.3mm
2/ms and R = 10:1), which is associated with early-
stage AF. (2) Diffuse fibrosis, where instead of ionic remodeling
the M-F coupling was added and inter-myocyte coupling was
decreased (DL = 0.12mm
2/ms, R = 10:1) throughout the atria,
both changes associated with short-term AF (Rook et al., 1992;
Li et al., 1999). (3) Interstitial fibrosis, where in addition to the
presence of diffuse fibrosis atrial tissue anisotropy was increased
(DL = 0.12mm
2/ms, R = 16:1), which is associated with high
level of collagenous depositions in long-term AF (Kawara et al.,
2001; Krul et al., 2015). (4) Patient-specific patchy fibrosis (DL ≤
0.3 mm2/ms, R= 10:1) introduced as described below.
The segmented distinctive fibrosis levels, indexed 0–5
depending on the LGE MRI intensity, were applied to simulate
the dense-to-diffuse fibrosis gradients in the 3D atrial model.
Index 0 represents no fibrosis, and regions with indices 1–5 are
modeled as increasingly severe fibrosis. Specifically, indices 0–
5 corresponded to progressively increasing M-F coupling (0–
5 fibroblasts per myocyte) and decreasing diffusive coupling
between myocytes (100–20% of the standard DL = 0.3 mm
2/ms).
Thus, 3 patient-specific fibrosis distributions were generated.
The tissue effective refractory period (ERP) was calculated in
a quasi-1D tissue by applying a stimulating current at one end to
initiate AP propagation to the other end. This was modeled as a
long 3D slab of 50 × 7 × 7 cells with a space step of 0.3 mm and
a diffusion coefficient of 0.3 mm2 ms−1. The stimulus of −2500
mA was applied in the first 10 layers of cells. This resulted in a
1D plane wave propagating along the slab. Stimuli were applied
at a given BCL, followed by a last stimulus applied at a variable S2
interval. The latter was increased until an AP was observed at the
non-stimulated end of the cable. The minimum S2 interval for
which AP was still able to propagate through the cable was taken
as ERP. These simulations also enabled the calculation of the
conduction velocity (CV) by measuring conduction times along
the slab.
Re-entry was initiated in the 3D model through fast pacing in
the RAA or LAA, allowing for the wave to propagate transversely
to the crista terminalis (CT) and generate a conduction block.
RESULTS
Atrial Fibroblast and M-F Coupling Models
The fitting of ionic channel currents in the atrial fibroblastmodels
to the respective patch-clamp data (Wu et al., 2014) can be seen
in Figures 3A–D. I-V curves for IKur , Ito and IK1 (Figures 3A–C)
in the model all are in good agreement with the experimental
data. After fitting the ionic currents to experimental data, the
RMP in the resulting model for a single atrial fibroblast was
−42.5 mV, which was in excellent agreement with the respective
experimental value of −42.8 mV recorded from atrial fibroblasts
(Wu et al., 2014). This value is more positive than the RMP of
−48 mV inMacCannell et al. (2007) ventricular fibroblast model,
although both are within the experimental data range (Table 1).
Coupling to fibroblasts significantly affected
electrophysiological properties of the myocyte. Figures 4A,B,
illustrates APs in the control CRN model (i) coupled to the
developed atrial fibroblast model (ii), and the CRN model for
a myocyte coupled to the MacCannell et al. (2007) ventricular
fibroblast model (iii). In these simulations, a myocyte was
coupled to 2 fibroblasts. The M-F model (ii) produced prolonged
repolarisation compared to the uncoupled control model (i),
while the M-F ventricular model (iii) produces a more rapid
repolarization than in control. Hence, coupling to atrial (ii) and
ventricular (iii) fibroblasts produces opposite effects on AP in the
CRN atrial myocyte model (i). Figures 4C,D show the respective
membrane potential in atrial and ventricular fibroblasts for the
M-F coupling models (ii) and (iii).
The fibroblast potentials were purely electrotonic due to the
coupling with the myocyte and had substantially lower amplitude
than that of the myocyte. The atrial fibroblast had a slower
repolarization and slightly lower amplitude than that of the
coupled ventricular fibroblast. More importantly, it had a higher
RMP, and hence a larger effect of the myocyte RMP.
Figure 5 compares electrophysiological characteristics of the
cases (i)-(iii). The RMP (Figure 5A) was increased (becamemore
positive) compared to control in both M-F coupling models (ii)
and (iii). At a BCL of 500 ms, in the M-F model (ii) with atrial
fibroblast the RMP was −76.5 mV (Figure 5A) and in the M-F
model (iii) with ventricular fibroblast the RMP was −77.5 mV,
compared to−79.8 mV in the uncoupled CRNmodel (i). RMP is
lowest in case (ii) throughout all BCLs, which can be particularly
important at fast rates associated with AF.
The dynamic effects of coupling a CRN myocyte with the
fibroblast models significantly changed the refractoriness of the
myocyte. There was little difference in APD between the M-
F coupling model with atrial fibroblasts (ii) and the control
(i) except for at a high pacing rate, e.g., at a BCL of 300
ms (Figure 5B). In comparison, the M-F coupling model with
ventricular fibroblasts (iii) reduced the APD throughout the
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FIGURE 3 | Ionic channel currents of the atrial fibroblast model. (A–C) The simulated I-V curves for the major ionic currents (solid lines) are shown along with the
respective experimental data (dots). (A) The ultra-rapid current, IKur. (B) The transient outward current, Ito. (C) The experimentally measured end-pulse current (black
dots), with the simulated inward-rectifier and non-specific currents, IK1 and Ins, (gray lines) and the combined current IK1 + Ins (black line). (D) IKv simulated by the
ventricular fibroblast model by MacCannell et al. (2007); it represent the sum of IKur and Ito. The index ‘f’ used in equations (1)–(4) above is omitted here for simplicity.
range of BCLs, with a maximum reduction of about 20 ms.
Effects of M-F coupling on APD became more pronounced
in both models (ii) and (iii) as the number of fibroblasts
coupled to a myocyte was increased from 2 to 4 and
6.
The excitation threshold for the stimulus current was also
investigated (Figure 5C) for the models. In the M-F coupling
model (ii) with atrial fibroblasts, the threshold was −15.9 pA/pF
at the BCL of 500 ms. It was significantly lower when compared
to both the uncoupled myocyte model (i) (−19.2 mA/mS)
and the M-F coupling model (iii) with ventricular fibroblasts
(−17.5 mA/mS). Changes of the excitation threshold in models
(ii) and (iii) compared to control CRN (i) correlated with the
respective changes in the RMP: higher (more positive, but lower
absolute value) RMP corresponded to the lower threshold (see
Figures 5A,C).
Effects of M-F coupling on ERP were larger than those on
APD in both M-F coupling models (ii) and (iii). ERP in the M-F
coupling model with atrial fibroblasts (ii) was larger than that in
control (i) by about 5–10 ms at BCLs above 300 ms (Figure 5D),
but dropped off rapidly at BCL was decreased below 275 ms. ERP
in the M-F coupling model with ventricular fibroblasts (iii) was
substantially larger than that in control (i) by about 50–100 ms
across the range of BCLs.
Despite decreasing the excitation threshold, both M-F
coupling models (ii) and (iii) reduced the CV compared to the
control (i), with the ventricular M-Fmodel producing the greater
reduction. This can be explained by a substantial reduction of
the sodium current, INa, in case (ii) (Figure 5F) and by a large
increase of the ERP in case (iii) (Figure 5D). The decrease of INa
in the myocyte, particularly pronounced due to coupling with
atrial fibroblasts at high rates (Figure 5F), can be explained by
more positive RMP in atrial fibroblasts (Figure 5A). The latter
results in a stronger electrotonic M-F current, IGap, (Figure 4)
and partial inactivation of INa.
Note that RMP in the novel atrial fibroblast model (−42 mV)
was more representative of atrial physiology (Table 1) than that
the MacCannell et al. (2007) ventricular fibroblast model (−47
mV), as it was developed based on more comprehensive patch-
clamp data from atrial fibroblasts. Moreover, M-F coupling with
the ventricular fibroblast model produced non-physiologically
high ERP (about 350ms) and low CV (0.4m/s) in atrial tissue
at high rates (BCL of 300ms). The high ERP in this case may be a
result of slow repolarisation processes, characterized by long time
constants, in the ventricular models–whereas our novel atrial
fibroblast model uses formalisms, including kinetics inherited
from the CRN model, specific to faster repolarisation in the
atria. Hence, using the ventricular fibroblast model instead of the
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FIGURE 4 | Effects of M-F coupling on AP in the atrial myocyte described by the CRN model. (A) And (B) show the AP in atrial myocyte in various conditions:
uncoupled CRN (blue), coupled with the human atrial fibroblast model (green) and coupled with the ventricular fibroblast model (red). (C,D) Show the fibroblast
membrane potential for the coupled models, and (E,F) show the M-F gap junctional coupling current (IGap). The left hand column (A,C, and E) shows these
conditions at a BCL of 250 ms and the right (B,D, and F) for a BCL of 500 ms.
atrial fibroblast model in 3D human atrial models could lead to
different behavior in AF, as shown in the next section.
Uniform Fibrosis in 3D Atrial Models
In 3D atrial simulations, fast pacing in the anterior RA resulted
in a conduction block leading to wave breaks and re-entry in
all simulated conditions (see Methods). The precise location and
timing of the wave-block varied depending on the condition
considered and pacing rate used, but was always clearly observed
between the CT and the pacing site (seen in Figure 6).
In the diffuse fibrosis conditions, M-F coupling with atrial
and ventricular fibroblasts resulted in greatly varying duration
of re-entry: about 3 and 12 s, respectively. A much longer
duration of re-entry in the latter case can be explained to
the wavelength reduction associated with extremely low CV
values seen with this model (Figure 5D) at high rates. The
short wavelength can be seen in Figure 6 as a larger excitable
gap (between a re-entering wave and the preceding one) in
the case of coupling with ventricular fibroblasts (Figures 6A,C),
as compared to that with atrial fibroblasts (Figures 6B,D).
This also points the sensitivity of 3D atrial behavior to the
choice of a fibroblast model, especially at high rates typical
of AF.
In all diffuse fibrosis conditions, re-entry was unstable and
self-terminated after several seconds (Figure 7B). In the ionic
remodeling condition, known to lead to a large decrease
of APD and the wavelength (Aslanidi et al., 2011; Colman
et al., 2013), a single stable rotor persisted through the entire
simulation (Figure 7A). Another pattern was observed in the
high anisotropy condition linked with interstitial fibrosis. Re-
entrant waves initiated due to the wave break at the CT and
a relatively short wavelength were afterwards broken down
into multiple secondary wavelets (Figure 7C). The breakdown
mechanism was due to the presence of a higher number of
sites with slow transverse conduction (similar to the CT).
The general 3D atrial activation pattern of multiple wavelets
propagating quasi-chaotically and independently was typical
of AF.
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FIGURE 5 | Electrophysiological characteristics of the M-F coupling models. (A), RMP; (B), APD; (C), Excitation threshold in respect to the stimulating
current; (D), CV; (E), ERP; (F), Peak sodium current, INa, all shown for increasing BCLs. All panels use the same colour code: uncoupled CRN myocyte model (blue),
M-F coupling model with atrial fibroblasts (green) and M-F coupling model with ventricular fibroblasts (red).
However, stabilization of sustained activity in specific atrial
locations was not observed in any of the uniform conditions
considered. In the next section, such a stabilization of re-entrant
wave is linked with patient-specific areas of heterogeneous patchy
fibrosis in the 3D atria.
Patient-Specific Fibrosis in 3D Atrial
Models
The segmentations of LGE MR images yielded different fibrosis
distributions in 3 AF patients. The reconstructed fibrosis
distributions varied in the extent and severity, as seen in
Figure 8. All datasets showed areas of more severe, dense
fibrosis (corresponding to the highest LGE MRI intensity) in
the posterior LA (Figure 8), which is a common ablation target.
The relative quantized distributions of fibrosis in the thresholded
datasets showed a higher distribution in the lower fibrosis
levels. Significantly lower amounts of fibrosis were observed
in the higher levels (4–5) despite the histogram bias for level
5 fibrosis. In all the datasets good connectivity of fibrotic
regions was observed, with the fibrosis levels changing gradually
(Figure 8).
In 3D atrial model simulations, variable duration pinning
to the fibrotic region was typically seen for all patient-
specific cases (Figure 9). Permanent rotor stabilization in
the BZ was seen in two cases, where rotor was pinned
until the end of simulation. One simulation produced rotor
movement directly around an inner area of dense fibrosis
(Figure 9A) and another within an adjacent border zone of
less severe patchy fibrosis (Figure 9B). In both cases, the
rotor core was localized within regions of broadly defined
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patchy fibrosis (levels 3–4). Spatio-temporal dynamics of
the rotors is illustrated in Figures 9C,D and Supplementary
Video 1.
In patient-specific 3D atrial model simulations with variation
of LGE MRI intensity threshold, different behaviors were
observed (Figure 10). In simulations with the higher thresholds
FIGURE 6 | Simulations of the 3D human atrial model with diffuse
fibrosis. The latter includes normal 10:1 anisotropy, 60% reduction of
diffusion coefficients and M-F coupling with 2 fibroblasts. (A) And (C) illustrate
simulations with the developed atrial fibroblast model, and (B,D) show those
with the MacCannell et al. (2007) ventricular fibroblast model. The top panels
(A,B) shows the initial conduction blocks (white lines), and (C,D) show re-entry
generation. 3D voltage maps (rainbow palette) are superimposed onto the
atrial geometry (transparent blue). Wave directions in the RA are indicated by
black arrows, with secondary waves travelling away into the LA.
(lower fibrosis level) no stable rotor pinning was observed, with
only short lived (less than 1 s) meandering re-entry in the LA
fibrotic regions in two patients (Figures 10A,B). Simulations
of the same two patient-specific atrial models with the lower
threshold (higher fibrosis level) showed severe wave breakdown,
with multiple re-entrant wavelets in the LA and to a lesser
extent the RA. Interactions of the wavelets in fibrotic regions
prevented the generation of a single rotor (Figures 10B,D). The
complex electrical activity in both patient-specific 3D atria was
characteristic of AF and sustained for the entire simulation
(10 s).
The 3D atrial simulations performed for this section provide
further evidence to the importance of using realistic fibrosis
patterns to study the dynamics of AF, and elucidate the role of
fibrosis in arrhythmogenesis due to the unique wave interactions
for different fibrotic distributions.
DISCUSSION
In this study, cell-to-organ models of the human atria were
developed and applied to explore the effects of fibrosis on AF
arrhythmogenesis. Fibrosis was modeled by integrating (i) a
novel electrophysiologically detailed model for a single atrial
fibroblast, (ii) electrotonic myocyte-fibroblast (M-F) coupling,
(iii) structural effects of fibrosis on anisotropic conductivity
of atrial tissue and (iv) either uniform or patient-specific
distributions of fibrosis in the 3D atrial model. Patient-specific
distributions were reconstructed from clinical LGE MRI and
angiography data, and a novel image processing pipeline was
developed to maps the distributions of fibrosis into the 3D atrial
model and investigate the effects of regional fibrosis patches
on AF.
The modeling revealed that: (1) electrophysiological
properties of atrial fibroblasts are different from those of
ventricular fibroblasts, with the largest effect of atrial M-F
coupling being on the myocyte RMP and INa, and leading
to a reduction of atrial CV; 2) further to the M-F coupling,
FIGURE 7 | Activation maps in the 3D atria model for typical patterns of observed re-entrant behaviours. (A) A stable rotor, seen in the conditions with ionic
remodelling. (B) Unstable re-entrant waves in the conditions with diffuse fibrosis. (C) wave breakdown in the conditions with interstitial fibrosis. Wave propagation
directions are shown by black arrows and wave-blocks are shown by white lines. In (B,C), the left atrium is fully activated at the initial moment of time t = 0 and the
PVs are repolarized and not activated (and hence, seen in the transparent blue color corresponding to the tissue geometry) within the range of these activation times.
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FIGURE 8 | Reconstruction of fibrosis by LGE MRI intensity threshold method from 3 AF patients. Variation in distribution can clearly be seen between
patients in panels (A–C). (A,C) Illustrate cases with lower thresholds and B shows a case with higher threshold. The palette below shows the reconstructed levels of
fibrosis, from diffuse (levels 1–2) to patchy (levels 3–4) and dense (level 5). 3D atrial geometry is also shown (transparent blue), similar to Figures 6, 9.
FIGURE 9 | Stabilization of rotors in patchy fibrosis regions. (A,B) Show
two different patient-specific fibrosis distributions, and (C,D) Show the
respective single rotor period activation maps (see color code in Figure 7).
The maps illustrate the variation of rotor pinning specific to the distributions of
fibrosis. Wave propagation direction is denoted by the black arrow, the core of
the rotor is indicated by the solid white shape and central dense fibrosis
regions are indicated by the dotted white lines. (C) Shows a rotor pinned
directly to a dense fibrotic region (the dynamics of rotor movement in this case
is illustrated by the Supplementary Video 1, and the respective fiber orientation
in the 3D atria is shown for comparison in the Supplementary Figure 1). (D)
Shows a rotor with the core adjacent to a dense fibrotic region, but rotating
within a border zone.
effects of fibrosis on tissue coupling and anisotropy greatly
reduce atrial CV; 3) heterogeneous distributions of patchy
fibrosis can result in rotor slowing and stabilization in
fibrotic borders. The latter result provides a mechanistic
explanation for the observations of recent studies (Jadidi
et al., 2013; Haissaguerre et al., 2016; Zahid et al., 2016)
linking patient-specific atrial fibrosis distribution and AF
arrhythmogenesis.
FIGURE 10 | Snapshots of re-entry in 3D atria with fibrosis
distributions based on high and low thresholds of LGE MRI intensity
datasets. (A,C) Show 2 patient cases with a high threshold (lower amount of
fibrosis) and (B,D) Show the respective cases with a low threshold (higher
amount of fibrosis). The rows delineate different patients (A–D). In the high
threshold cases (A,C), only a short lived rotor (indicated) was present in the
LA. In the high threshold cases (B,D), multiple re-entrant waves are present in
the LA fibrotic regions. White dashed and dotted lines indicate level 5 (dense)
and levels 3–4 (patchy) levels of fibrosis, respectively. 3D voltage maps are
superimposed onto the atrial geometry (see color code in Figure 6).
Atrial Fibroblast Model
A novel model for atrial fibroblast electrophysiology was
developed based on experimental data by Wu et al. (2014)
and applied to study the effects of M-F coupling with the
atrial myocyte. Atrial fibroblasts in the model had higher (more
positive) RMP compared to the previous models of ventricular
fibroblasts byMacCannell et al. (2007) and hence a stronger effect
on the excitability of atrial myocytes. This is in agreement with
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previous studies showing that the RMP of fibroblasts can have
significant effects on AP properties of the myocyte (Jacquemet
and Henriquez, 2008; Maleckar et al., 2009).
During the early phases of AP, fibroblasts in theM-Fmodel act
as a current sink effectively reducing the upstroke of the myocyte,
with the AP amplitude (APA) reduced by 5 mV with the atrial
fibroblast model (Figure 4). Similar behavior has been shown in
other studies (Jacquemet and Henriquez, 2008; Maleckar et al.,
2009), but with larger M-F coupling conductances. The APA
reduction can slow down the propagation in atrial tissue due
to the reduced electrotonic current transferred to neighboring
myocytes. During the later phases of the AP, the fibroblasts in the
M-F model act as a current source, prolonging the repolarisation
phase (Figure 4) and increasing ERP (Figure 5E) in the
myocyte.
The latter result is similar to the findings by Jacquemet
and Henriquez (2008) and Maleckar et al. (2009) who both
used a modified MacCannell et al. (2007) model for ventricular
fibroblasts. However, the greatly prolonged ERP in the atrial
myocyte coupled to ventricular fibroblasts (Figure 5E) is non-
physiological, and also results in non-physiologically large
reductions in atrial CV (Figure 5D). Coupling to the novel
atrial fibroblast model produced more physiological values of
atrial ERP and CV (Figure 5). A relatively small CV decrease
in this case also had a different mechanism. The excitation
threshold in the myocyte coupled to atrial fibroblasts was
decreased (Figure 5C) due to increased RMP in the myocyte
(which was caused by inflowing IGap from the atrial fibroblasts
with relatively higher RMP). Counter-intuitively, the decreased
threshold did not result in increased atrial CV–in fact, CV was
significantly decreased (Figure 5D). This was due to the inflow
of IGap into the myocyte leading to a partial inactivation of INa
(Figure 5F).
Thus, the developed model for atrial fibroblast is more
relevant to atrial electrophysiology (Table 1) than the existing
ventricular fibroblast models, and also provides more relevant
insights into the arrhythmogenic effects of M-F coupling in the
atria. The latter include CV reductions that can be responsible
for regional conduction blocks and the generation of re-entrant
waves. The fibroblast model provides a valuable tool for further
studying AF in 3D atrial models. The model could be further
validated if novel data from human atrial fibroblasts become
available.
3D Effects of Uniform Fibrosis
The 3D atria modeling enables exploring the interplay between
effects of fibrosis on atrial structure and function and the
resulting AF scenarios. Three uniform effects of AF-induced
remodeling in the entire 3D atrial model were considered: ionic
remodeling, diffuse fibrosis (M-F coupling + decreased M-M
coupling) and interstitial fibrosis (diffuse fibrosis + increased
atrial tissue anisotropy). Simulations showed a range of re-
entrant behaviors (Figure 7).
Similar to previous studies (Colman et al., 2013), the 3Dmodel
was first validated against atrial activation data in sinus rhythm,
demonstrating a good agreement with clinical measurements by
Lemery et al. (2007) Further simulations of ionic remodeling
effects also agreed with previous results (Aslanidi et al., 2011;
Colman et al., 2013), showing a stable rotor in the 3D atrial model
in the case when M-M coupling was normal (Figure 7A). This
was due to the remodeling greatly decreasing atrial APD, and
therefore the wavelength.
In case of diffuse fibrosis, simulations produced unstable
re-entry that self-terminated after several seconds. This was
due to the fact that APD and ERP in this case was relatively
high (Figures 5A,E, 7B), which resulted in a long wavelength
comparable to the size of the atria. Re-entry was sustained longer
in the model with coupling to ventricular fibroblasts compared
to atrial fibroblasts (12 vs. 3 s), due to low CV (Figure 5D),
and hence the wavelength (Figure 6), in the former case. These
results also point to the sensitivity of 3D atrial behavior to the
choice of a fibroblast model, which should be relevant to atrial
electrophysiology.
In case of interstitial fibrosis, AF-induced increase in tissue
anisotropy (Kawara et al., 2001; Koura et al., 2002; Verheule et al.,
2013; Angel et al., 2015; Krul et al., 2015) resulted in multiple
conduction blocks and wave breakdown throughout the 3D atria
(Figure 7C). This was the only condition where the 3D atria
model produced a sustained AF-like patterns with multiple re-
entrant wavelets. Overall, changes of the 3D wave dynamics due
to the increased anisotropy were more significant than the effects
ofM-F coupling or wavelength reduction due to ionic remodeling
(Figure 7). This suggests that the structural effects of fibrosis,
which develop in later stages in AF progression, may play the
most important role in AF sustenance. However, stabilization
of sustained activity in specific atrial locations (Haissaguerre
et al., 2016), was not observed in any of the uniform cases,
and can only be seen with heterogeneous distributions of
fibrosis.
Effects of Patchy Fibrosis in 3D Atria
The 3D atrial simulations demonstrated unique wave interactions
with different fibrotic distributions, and hence the importance of
using patient-specific LGE MRI data to study AF.
The reconstructed LGE MRI patient datasets showed
increased fibrosis distribution on the LA posterior wall
(Figure 8). This region may be statistically prone to fibrotic
infiltration and is often a site where complex fractionated
electrograms are identified, which are common targets for
ablation. The lower extent of fibrosis on the LA roof and
floor may be due to the lower Z axis resolution of the
MRI scan. Regardless of limitations of the imaging method,
LGE MRI intensity has been strongly linked to fibrosis, and
the reconstructed fibrosis distributions agree with existing
knowledge from various modalities.
In 3D atrial simulations with patient-specific fibrosis
distribution, a clear stabilization of rotors in regions of patchy
fibrosis was observed in 2 out of 3 cases. One case produced
a larger circus movement around a dense fibrosis region
(Figure 9C) and another produced a smaller extent movement
along the border of a dense region (Figure 9D). In both
cases, rotors moved in slow-conducting BZ of patchy fibrosis
surrounding inner regions of dense fibrosis. Note that fiber
orientation can also be important in determining the rotor
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dynamics (Colman et al., 2014). However, in our simulations
slow conduction in the fibrotic BZ appeared to be the main
determinant of the rotor location–without patchy fibrosis, rotors
meandered freely as seen in Figures 6, 7.
Further simulations also showed that patient-specific fibrosis
distributions can induce wave breakdown (Figure 10) which is
symptomatic of AF. This was only observed in simulation of
high levels of fibrosis (obtained with a low LGE MRI intensity
threshold) and resulted in permanent AF for the duration of
the simulation (10 s). Smaller re-entrant wavelets were observed
in these simulations moving chaotically throughout the fibrotic
region. Contrarily, simulations of lower levels of fibrosis in the
same patient (obtained by using a higher LGE MRI intensity
threshold) produced very short duration re-entry that was neither
stable nor resulted in wave breakdown. Note that the overall
amount of fibrosis was not very different between the high
and low thresholds. Rather, fibrosis was redistributed toward
a higher proportion of severe fibrosis (levels 3–5) with an
overall longer slow-conducting BZ. Hence, the rotor dynamics
in AF may be determined primarily by the presence of such
distributions.
Our results are in agreement with previous computational
studies of atrial fibrosis: McDowell et al. (2015) and later Zahid
et al. (2016) have shown that rotors in 3D atrial models can be
localized near areas of fibrosis introduced based on LGE MRI
data. Similar observations were made in cases of discrete fibrotic
zones (Zahid et al., 2016), statistical distributions of fibrotic
properties from dense fibrosis to healthy tissue (McDowell et al.,
2015), and the respective continuous distributions in the current
study. Hence, the mechanism of rotor stabilization proposed in
our study can be independent on a specific way of modeling
fibrosis. The accuracy of modeling fibrosis can be important
for finding precise location of the rotors, and our approach of
reconstructing continuous areas of patchy fibrosis may provide
an advantage over models based on binary (Zahid et al., 2016) or
statistical (McDowell et al., 2015) reconstructions.
LIMITATIONS
One of the major limitations of this work is a lack of
experimental validation for the electrophysiological effects of
fibrosis at the atrial cell and tissue level, such as its effects
on APD and ERP. However, the same lack of data highlights
the importance of modeling and simulation in order to better
understand the problem. Further experimental measurements in-
vivo are required for the validation of the M-F coupling effects
observed in the models. Another is a lack of comprehensive
clinical validation at the 3D atrial level, although results of our
simulations are in agreement with observations of the existing
studies (Jadidi et al., 2013; Haissaguerre et al., 2016; Zahid et al.,
2016).
Although LGE MRI and the threshold segmentation methods
also require further validation, this study aimed to investigate the
effect of substantial fibrosis regions, which can be clearly seen in
LGE MR images. The difference between the high and low levels
of fibrosis also shows that the developed image processing and
modeling pipeline is sensitive to the choice of parameters (such as
LGEMRI intensity threshold) and can yield very different results.
Whilst the quantification for LGE MRI intensity and amount of
fibrosis from patients is currently limited, the LGEMRI intensity
should indicate areas of higher fibrosis (McGann et al., 2014) in
comparison to the rest of the tissue. The LGE MR images may
also suffer from partial volume averaging, in which neighboring
tissues influence the wall mask because of the coarse resolution of
the image.
CONCLUSION
Clinically observed correlation between AF progression and
fibrosis levels in the atria have led to suggestions of an empirical
link between the two. The aim of this work was to understand
and substantiate this link with the aid of mechanistic cell-to-
organ atrial modeling. We showed that both structural and
functional effects of fibrosis result in reduction of atrial CV,
and that rotors sustaining AF typically propagate in the slow
conducting BZs of patchy fibrosis. These findings provide a
mechanistic explanation for the improved outcomes of ablation
around fibrotic areas, which can be based on the elimination of
the slow-conducting substrate in the fibrotic BZ (fibrosis levels
3–4), and may help in future patient-specific planning of such
procedures.
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